Related Experiment Video
Updated: Jun 18, 2026
Exploring Mitochondrial Energy Metabolism of Single 3D Microtissue Spheroids Using Extracellular Flux Analysis
Published on: February 3, 2022
Effect of afobazole on mitochondrial monoamine oxidase A activity in vitro
M V Voronin1, L N Aksenova, O A Buneena
1Laboratory for Pharmacogenetics, V. V. Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow, Russia. niipharm@mail.ru
Abstract:
Selective anxiolytic afobazole (1 mM) inhibits monoamine oxidase A activity in mitochondria from rat brain and liver (IC(50) 0.36 and 0.43, respectively). Effect of the compound does not depend on the time of preincubation with mitochondria. Triple washout of mitochondria is followed by complete recovery of initial enzyme activity.
Insights
Selective anxiolytic afobazole inhibits monoamine oxidase A in rat brain and liver mitochondria. Enzyme activity fully recovers after afobazole washout, indicating a reversible inhibitory effect.
Area of Science:
- Biochemistry
- Pharmacology
- Neuroscience
Background:
- Monoamine oxidase A (MAO-A) is a key enzyme in neurotransmitter metabolism.
- Selective anxiolytics are investigated for their potential to modulate MAO-A activity.
- Understanding the interaction between afobazole and MAO-A is crucial for its therapeutic application.
Purpose of the Study:
- To investigate the effect of afobazole on monoamine oxidase A activity.
- To determine the inhibitory concentration (IC50) of afobazole on MAO-A in rat brain and liver mitochondria.
- To assess the reversibility of afobazole's inhibition on MAO-A activity.
Main Methods:
- Mitochondria were isolated from rat brain and liver.
- Monoamine oxidase A activity was measured in the presence of varying concentrations of afobazole.
- Inhibition kinetics and reversibility were assessed through preincubation and washout experiments.
Main Results:
- Afobazole (1 mM) demonstrated significant inhibition of MAO-A activity in both rat brain and liver mitochondria.
- The IC50 values for afobazole inhibition of MAO-A were determined to be 0.36 in brain and 0.43 in liver mitochondria.
- The inhibitory effect of afobazole was independent of preincubation time and fully reversible upon washout.
Conclusions:
- Afobazole acts as a reversible inhibitor of monoamine oxidase A in rat brain and liver mitochondria.
- The findings suggest a potential mechanism for afobazole's anxiolytic effects through MAO-A modulation.
- Further research is warranted to explore the therapeutic implications of afobazole's reversible MAO-A inhibition.
